Search Results 1-10 of 5070 for Suchmaschinen 🔍 www.41.gs
9-ING-41 has anti-cancer clinical activity while not causing myelosuppression, and has both pre-clinical anti-fibrotic activity and activity against ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... 41:05-06:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/about-mayo-clinic/care-network/amplified-expertise ...
ICD-11 World Health Organization.
TC215 International Organization for Standardization.
Participants in each part will receive either active GS-5745 or a placebo. Participation eligibility. Participant eligibility includes age, gender, type and ...
The purpose of this study is to evaluate the safety and effectiveness of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with ...
... 41:00-05:00</lastmod><xhtml:link rel="alternate" hreflang="es" href="https://www.mayoclinic.org/es/diseases-conditions/multiple-sclerosis/expert-answers ...
... 41-05:00</lastmod><xhtml:link rel="alternate" hreflang="es" href="https://www.mayoclinic.org/es/rochester-construction/update-4th-ave-sw-closure" /><xhtml ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.